CVRdatabase
Menu

IntuBio ApS

Private limited companyCVR 39719010FarumActive

IntuBio ApS is a private limited company, based in Farum, active in research and experimental development on natural sciences and engineering, founded in 2018. The company made a loss in both 2024 and 2025, most recently DKK 751k. Equity fell to DKK 620k in 2025. 5 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 2.1m−8.2% vs. 2024
Net profit−DKK 751k−78.3% vs. 2024
EquityDKK 620k−54.8% vs. 2024
Employees5latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 8% (2024 → 2025), to DKK 2.1m.
  • The loss grew: from DKK 421k to DKK 751k (2024 → 2025).
  • Equity fell 55% (2024 → 2025), to DKK 620k.

Employees

  • 1 more employees than a year earlier: 5 (07/2026) against 4 (07/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 1m−DKK 500kDKK 0DKK 500kDKK 1mDKK 1.5m202020212022202320242025
EquityNet profit
Financial figures for IntuBio ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit4062,2832,6794,1272,2962,108−8.2%
Operating profit (EBIT)−8134173342,005−319−738−131.1%
Profit before tax−9122581801,776−539−979−81.4%
Net profit−6783653701,396−421−751−78.3%
Total assets2,4102,7933,8336,1656,0705,582−8%
Equity−422−573131,7091,371620−54.8%
Liabilities2,8322,8503,5064,0624,4234,745+7.3%
Cash and cash equivalents2,0628962706441,750453−74.1%
Average number of employees2333330%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 1mDKK 2mDKK 3mDKK 4m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 2 years in a row

    Net result has been negative in 2024–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 55% from 2024 to 2025 (DKK 1.4m to DKK 620k).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for IntuBio ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202519/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202415/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202310/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202207/03/2023The companyPDFXBRL
202101/01/2021 – 31/12/202101/07/2022The companyPDFXBRL
202001/01/2020 – 31/12/202028/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
012345608/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 2.1mNo. 155 of 421
Better than 63% of the companies in the industry
EquityDKK 620kNo. 257 of 431
Better than 40% of the companies in the industry
Number of employees5No. 254 of 431
Better than 41% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 29,831of 69,742
Better than 57%
No. 39,646of 69,964
Better than 43%
Same industry and fewer than 20 employees329 companies in the comparison
No. 84of 323
Better than 74%
No. 167of 329
Better than 49%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 16,407of 33,588
Better than 51%
No. 18,573of 33,687
Better than 45%
All companies of type ApS66,508 companies in the comparison
No. 28,982of 66,379
Better than 56%
No. 35,541of 66,505
Better than 47%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. IntuBio ApSDKK 2.1m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. IntuBio ApS−DKK 751k
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. IntuBio ApSDKK 620k
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. IntuBio ApS5
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Fastflow Systems ApS25%
  • Famole G2 Holding ApS25%
  • Agersnap Technologies ApS25%
  • Ole Falholt Holding ApS10%
IntuBio ApS

Management

3 active registrations

Executive management

Executive management at IntuBio ApS
NameRoleAppointed
Tom OlesenCEO31/05/2023

Board of directors

Board of directors at IntuBio ApS
NameRoleAppointed
Tom OlesenChair of the board04/07/2018
Niels Agersnap LarsenBoard member04/07/2018
Founders
Agersnap Technologies ApS
Former management (3)
Former management at IntuBio ApS
NameRoleAppointedResigned
Niels Agersnap LarsenCEO04/07/201810/06/2021
Erik SpillumBoard member04/07/201831/05/2023
Ole FalholtDirector10/06/202131/05/2023

Signing rule: Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Hirsemarken 1
3520 Farum

Furesø Municipality · Postcode 3520

Other companies at the address (5)

Production units
Production unitAddressEmployeesP number
IntuBio ApSHirsemarken 1, 3520 Farum51023788809

Purpose

Selskabets formål er at drive virksomhed med handel og service samt aktiviteter, der efter bestyrelsens skøn er forbundet hermed.

The purpose is quoted from the register in Danish.

Changes year by year

34 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changescapital 1 · accounts 1
  • Share capital changed from 134,000 DKK to 136,735 DKK
  • Annual report for 2023 published
20238 changesownership 4 · management 3 · accounts 1
  • Agersnap Technologies ApS registered as owner (25%)
  • Ole Falholt Holding ApS registered as owner (10%)
  • Ole Falholt Holding ApS is no longer registered as owner
  • Agersnap Technologies ApS is no longer registered as owner
  • Tom Olesen appointed ceo
  • Ole Falholt stepped down as director
  • Erik Spillum stepped down as board member
  • Annual report for 2022 published
20221 changeaccounts 1
  • Annual report for 2021 published
20213 changesaccounts 1 · management 2
  • Annual report for 2020 published
  • Ole Falholt appointed director
  • Niels Agersnap Larsen stepped down as ceo
20208 changescapital 1 · ownership 7
  • Share capital changed from 50,000 DKK to 134,000 DKK
  • Ole Falholt Holding ApS registered as owner (20%)
  • Agersnap Technologies ApS registered as owner (20%)
  • FASTFLOW SYSTEMS ApS registered as owner (25%)
  • Famole G2 Holding ApS registered as owner (25%)
  • Spillum Holding ApS is no longer registered as owner
  • Agersnap Technologies ApS is no longer registered as owner
  • Famole G2 Holding ApS is no longer registered as owner
20189 changesname 1 · founded 1 · management 4 · ownership 3
  • Name changed from BioCon Technologies ApS to IntuBio ApS
  • Registered as BioCon Technologies ApS
  • Niels Agersnap Larsen appointed ceo
  • Erik Spillum appointed board member
  • Tom Olesen appointed chair of the board
  • Niels Agersnap Larsen appointed board member
  • Spillum Holding ApS registered as owner (5%)
  • Agersnap Technologies ApS registered as owner (50%)
  • Famole G2 Holding ApS registered as owner (33.33%)

Related companies

Same industry in Furesø

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction